葡萄牙医学肿瘤科住院部长期住院特征观察性研究
Characterization of prolonged hospital stays on a Medical Oncology Department in Portugal
该回顾性观察研究纳入葡萄牙里斯本 Incanco 医学肿瘤科 2023 年上半年 434 例住院病例,识别出 138 例长期住院(住院时间≥16 天),涉及 132 名患者,平均住院 35 天。长期住院组显著少于合并症、晚期治疗线数及入院原因数量。
Introduction
Cancer is the second leading cause of death in Portugal, the first being cardiovascular disease. Despite ongoing oncological research and important developments, improvements in cancer-related mortality over the recent decades are still considered insufficient. Between 2000 and 2018, Portugal recorded the second most significant relative reduction in potential years of life lost due to malignant tumors among EU countries. In 2018, malignant tumors accounted for 1,440 years of life lost per 100,000 individuals under 75 years old. Cancer mortality in Portugal is predominantly attributed to lung and colorectal cancers1.
Malignancies represent a complex group of diseases, and cancer patients exhibit diverse needs throughout their cancer journey. The inpatient unit of the Medical Oncology department where this observational study was conducted consists of 56 beds and admits hundreds of patients annually, including admissions for antineoplastic therapy, diagnostic procedures, toxicity management, disease progression, symptom management, social frailty, and end-of-life care.
Hospital LOS is one of the most widely used indicators to assess healthcare quality and efficient allocation and management of health care resources. LOS refers to the total number of bed-days occupied by a patient between admission and discharge2. Prolonged hospitalizations carry well-documented risks including nosocomial infections, falls, and loss of functional autonomy, as well as imposing substantial financial burden on healthcare systems and families.
With thousands of patients in active cancer care, efficient bed management is imperative to optimize resources and mitigate the deleterious consequences of prolonged hospitalizations. To achieve this, it is essential to review the characteristics of hospitalized patients, particularly among those with prolonged hospital stays.
Materials and methods
This study was guided by principles of quantitative observational research, with a retrospective nature. It was conducted in the Medical Oncology department of Instituto Português de Oncologia de Lisboa Francisco Gentil and included all hospital stay episodes with discharge dates between January 1st and June 30th, 2023.
Hospitalizations lasting 48 hours or less were excluded to minimize bias caused by elective hospital admissions for antineoplastic treatments.
The non-prolonged hospitalization group (LOS < 16 days) which was admitted during the same period was included as the control group for comparative analyses.
The following definitions were adopted for the purposes of this study:
-
“Prolonged hospital stay” is defined as a duration equal to or exceeding the sum of the mean hospitalization duration plus one standard deviation (≥ 16 days). This threshold was derived internally, as a systematic review of the literature did not yield a formal, consensus-based international definition of prolonged hospitalization in oncological settings; published thresholds vary considerably depending on clinical context, country, and case-mix;
-
“Social frailty” is a progressive state of vulnerability to the loss of resources necessary to fulfil basic social needs3;
-
“Cognitive impairment” is a condition with problems in thinking, reasoning, memory, or attention4;
-
“Motor impairment” refers to physical restrictions in movement or coordination5;
-
“Family meeting” (FM) is a structured multidisciplinary meeting with patient, family and care team to discuss prognosis and care planning.
Statistical analysis
Continuous variables were described as mean ± standard deviation and range. Group comparisons used the Mann-Whitney U test. Categorical variables were compared using Pearson’s chi-square or Fisher’s exact test (expected cells fewer than 5). For categorical variables with more than 2 levels, a global chi-square was performed followed by Fisher’s exact test per category.
Independent predictors of prolonged hospitalization were identified using binary logistic regression. Variables were selected for inclusion in the multivariate model based on statistical significance in univariate analysis and conceptual distinctiveness. Odds ratios (OR) and 95% confidence intervals were derived from the observed Fisher information matrix. The significance level was α = 0.05.
Results
Study population
Of 434 hospitalization episodes meeting inclusion criteria, 138 episodes of prolonged hospitalization (LOS ≥ 16 days) were identified, involving 132 patients. The mean duration of hospitalization was 35 (16–127) days. Prolonged hospitalizations represented 43% of bed occupancy during the first semester of 2023. Among the patients responsible for the 138 episodes, six experienced two prolonged hospitalization episodes within this period. The remaining 296 episodes (68.2%) constituted the non-prolonged control group, with an average duration of 8 (2–15) days.
Baseline and clinical characteristics
The distribution of patients by residence district was similar between groups. In both groups, most patients resided in Lisbon (57.2% vs. 60.5%), followed by neighbouring districts—Setúbal, Santarém and Leiria (35.5% vs. 32.1%)—and more distant districts (7.2% vs. 7.4%). No statistically significant difference in district distribution was found between the prolonged and non-prolonged groups (χ2 = 0.50, df = 2, p = 0.779).
Portuguese nationality was more frequently recorded in the prolonged group (87.0% vs. 79.1%, p = 0.048), though no significant difference was found for sex (p = 0.069).
Table 1 presents the comparison of continuous variables between groups. The mean age was similar (62.7 ± 13.4 vs. 61.6 ± 13.1 years, p = 0.326). Prolonged stay patients had significantly fewer comorbidities (1.6 ± 1.4 vs. 2.1 ± 1.4, p < 0.001), fewer lines of advanced-disease therapy (1.5 ± 1.7 vs. 1.8 ± 1.7, p = 0.032), and fewer admission reasons per episode (1.4 ± 0.6 vs. 1.7 ± 0.7, p < 0.001).
When comparing comorbidity profiles between groups, five categories were significantly more frequent in the non-prolonged group: benign gastrointestinal disease (13.9% vs. 2.2%, p < 0.001), addictive disorder (10.5% vs. 0.7%, p < 0.001), vascular disease (4.1% vs. 0.0%, p = 0.012), benign gynecological disease (5.7% vs. 0.7%, p = 0.017), and osteoarticular disease (14.2% vs. 7.2%, p = 0.040). No comorbidity category was significantly more frequent in the prolonged group. The remaining comorbidities, including cardiovascular risk factors, cardiac disease, thromboembolic disease, and haemato-oncological disease, showed comparable distributions between groups.
Table 2 presents comparisons of binary variables. Prolonged stay patients had significantly higher rates of in-hospital palliative care team (HPCT) involvement (65.9% vs. 31.1%, p < 0.001), PCU referral (31.9% vs. 4.7%, p < 0.001), social services support (74.6% vs. 28.4%, p < 0.001), family meetings (43.5% vs. 7.4%, p < 0.001), in-hospital mortality (35.5% vs. 22.0%, p = 0.003), and mortality within one month of discharge (27.0% vs. 13.4%, p = 0.004).
The in-hospital palliative care team was involved in 91 (65.9%) of the longer hospitalization episodes. Of these, approximately half were referred to a palliative care unit (Table 3 summarizes PCU referral criteria in Portugal) (n = 44, 48.4), with only 19 patients ultimately being transferred. Patients transferred to a PCU had a longer median hospital LOS compared to those referred but not transferred (41 vs. 27 days, p = 0.002). Transfer to PCU was also more frequent in the prolonged group (13.8% vs. 2.4%, p < 0.001). Disease context was predominantly palliative in both groups, but significantly more so in the prolonged group (94.9% vs. 82.4%, p = 0.001).
Additionally, 103 (74.6%) of the hospitalization episodes included evaluation and support from social services, and in 60 (43.5%) family meetings (FM) were held. A significant difference in LOS was observed between episodes with and without FM (median 32 vs. 22.5 days, p = 0.001).
Cancer type
The types of malignancies with the highest number of prolonged hospitalizations were gynecological (n = 26, 18.8%), upper GI (n = 22, 15.9%), breast (n = 22, 15.9%), and head and neck (n = 21, 15.2%). The distribution of cancer types differed significantly between groups, as detailed in Table 4: gynecological cancers were over-represented in the prolonged group (18.8% vs. 9.8%, p = 0.013), while sarcomas predominated among non-prolonged stays (15.2% vs. 7.2%, p = 0.020).
Reasons for hospitalization
Admission reasons divided into two opposing profiles (Table 5). Functional and palliative reasons—motor impairment (31.2% vs. 10.1%, p < 0.001), end-of-life care (26.8% vs. 7.1%, p < 0.001), cognitive impairment (10.9% vs. 2.7%, p < 0.001), and social frailty (11.6% vs. 3.7%, p = 0.003)—were significantly more frequent in prolonged stays. Conversely, acute resolvable conditions—metabolic imbalances (3.6% vs. 24.0%, p < 0.001), other medical complications (0.0% vs. 17.9%, p < 0.001), treatment toxicity (3.6% vs. 16.6%, p < 0.001), and infections (26.1% vs. 39.9%, p = 0.005)—predominated in non-prolonged stays. Fig. 1 illustrates the distribution of reasons for hospitalization among patients in the prolonged hospitalization subgroup.
Reasons for hospital admissions on the subgroup of long hospital stays.
Multivariate analysis
Logistic regression identified four independent predictors of prolonged hospitalization: intra-hospital department transfer (OR 7.88, 95% CI 1.97–31.6, p = 0.004), PCU referral (OR 5.33, 95% CI 1.66–17.1, p = 0.005), social services involvement (OR 4.71, 95% CI 2.47–9.0, p < 0.001), and family meetings (OR 3.00, 95% CI 1.41–6.4, p = 0.004).
Discussion
Hospitalization in cancer patients can naturally occur during the course of the disease. An Australian study linked prolonged hospitalizations to clinical factors that served as surrogates of disease severity, such as referral to a palliative care team, mechanical ventilation, admission to intensive care units or surgical procedures7. Among the risks associated with inappropriately prolonged hospital stays, the main concerns are clinical - examples include the risk of nosocomial infections, falls and loss of autonomy due to extended immobilization, all contributing to increased morbidity and mortality8.
On the other hand, prolonged hospitalizations may impose economic challenges at multiple levels, requiring the careful management of the available (finite) resources9. The costs associated with prolonged hospital stays are significant, representing a substantial financial burden for healthcare systems and, potentially, for patients and their relatives. In addition to direct costs, indirect costs such as loss of productivity and the economic impact on patients’ families also contribute to the overall financial burden. Furthermore, the need for continued and home care following discharge may also increase the total costs of care.
Discharging patients after a prolonged hospital stay demands the coordination of a wide range of professionals, including healthcare providers, families, caregivers, and social support institutions 8. An American study identified insufficient discharge site coordination as the most frequent non-clinical factor prolonging hospital stays, affecting 56% of patients with prolonged hospitalizations and causing an average delay of 8.5 days in discharge10.
Although the study was limited to a six-month period, the inclusion of all episodes of prolonged hospital stay ensures that the data analyzed are representative of real-world experience, encompassing a diversity of diagnoses and different stages of oncological disease.
Not all correlations tested among the various subgroups were pre-planned, as some were suggested by the data. Although this multiplicity of post-hoc analyses carries a risk of false positives, we consider these findings to carry value, from an exploratory perspective.
Prolonged stays and systemic predictors
The strongest independent predictors of prolonged hospitalization are organizational and systemic in nature - social services involvement (OR 4.71), PCU referral (OR 5.33), intra-hospital department transfer (OR 7.88), and family meetings (OR 3.00) – rather than markers of clinical complexity alone. Whether these associations represent modifiable determinants of prolonged stay or surrogate markers of underlying disease severity warrants prospective investigation. These findings are consistent with the American data on discharge site coordination cited above10.
Social frailty and discharge planning
Social frailty emerged as both a univariate correlate and a multivariate predictor of prolonged stay. The association between social services involvement and prolonged hospitalization is consistent with the hypothesis that, in a subset of cases, the absence of a timely discharge destination—rather than acute clinical need—may contribute to extended stays. This would reflect a structural gap in the coordination between acute hospitals and community services in Portugal, though the cross-sectional nature of the data does not allow causal inference.
Palliative care access
A clinically significant finding is the scale of apparent unmet palliative care need. Of the 138 prolonged stays, 47.8% met formal criteria for PCU admission, yet only 19 patients (43.2% of those referred) were successfully transferred. Sixty-six patients (47.8%) presented clinical criteria justifying referral to a PCU, but the referral process was not completed for three main reasons: reduced life expectancy contraindicating the transfer, patient refusal, or irregular residency status precluding referral to a PCU. Of those referred but not transferred, 80% died during the hospitalization itself. This pattern is consistent with the hypothesis that PCU waiting times may represent a rate-limiting step in access to appropriate end-of-life settings—a finding congruent with the well-documented scarcity of this resource in Portugal. A landmark Portuguese study demonstrated that a hospital stay exceeding 14 days was the most common single indicator of end-of-life therapeutic aggressiveness, with a prevalence of 43%11. Our cohort (LOS ≥ 16 days) falls squarely within this high-risk group. These findings suggest that the oncology ward may be serving, in part, as a default end-of-life environment for patients who cannot access timely PCU placement, though prospective data with timestamped records would be required to confirm this interpretation.
Admission reasons: two distinct clinical archetypes
The bimodal distribution of admission reasons is informative. Prolonged stays are characterized by functional and palliative reasons which by their nature do not resolve within days. Non-prolonged stays are dominated by acute, resolvable conditions. The protective effect of a higher number of admission reasons (OR 0.34) reflects that multi-reason episodes tend to be acute and resolvable, whereas single-reason prolonged stays tend to involve intractable functional dependence or lack of a discharge destination.
Cancer type and risk stratification
Gynecological cancers were significantly over-represented in the prolonged group (18.8% vs. 9.8%, p = 0.013) and sarcomas in the non-prolonged group (15.2% vs. 7.2%, p = 0.020). The reasons underlying these differences were not directly studied and warrant further investigation, including analysis of admission reasons, functional status, and social support needs by tumour type.
Limitations
This study has its limitations that should be considered when interpreting the findings described.
As a retrospective study, data collection relied on clinical records, and the six-month time frame, while representative, limits generalizability.
The definition of prolonged hospitalization (≥ 16 days) was center-specific, in the absence of a validated international consensus definition. This limits direct comparison with studies using different thresholds and restricts the generalizability of the findings to settings with a similar case-mix and patient profile.
The absence of a matched control group is also acknowledged. This study was not designed as a case-control study, and given its retrospective nature, formal matching would not have been feasible. The non-prolonged group represents all episodes occurring in the same period that did not meet the prolonged stay threshold, differing from the prolonged group in baseline characteristics and introducing a risk of residual confounding. Future prospective studies should consider matched designs or propensity score adjustment to better isolate the independent contribution of each predictor.
An important characteristic absent from the population description, and relevant in this type of study, is performance status. Whether assessed by the Eastern Cooperative Oncology Group scale, the Karnofsky Performance Scale, or other validated instruments, performance status requires prospective evaluation at a defined point in time and in the direct presence of the patient; it is not systematically documented in inpatient medical records at our institution and was therefore not available for most episodes. Retrospective imputation from clinical notes would introduce unvalidated proxies not methodologically comparable to the prospectively assessed tools and was not attempted. The admission reasons recorded in our dataset—motor impairment, cognitive impairment, end-of-life care, and social frailty—capture partial information about functional trajectory, but are not equivalent to a validated performance scale.
An important interpretive limitation concerns the directionality of the observed associations. Variables such as PCU referral, family meetings, and social services involvement may, in many cases, have been initiated as a consequence of a prolonged stay rather than preceding it. In this retrospective analysis, the temporal sequence of events cannot be reliably established. Furthermore, these palliative care-related variables are strong surrogates of disease severity and clinical complexity; the associations observed may therefore reflect, at least in part, confounding by underlying disease burden rather than independent structural relationships.
The multivariate model was not accompanied by a formal collinearity assessment. Several variables included in the analysis are conceptually related—particularly those reflecting palliative care involvement—as patients with advanced oncological disease tend to trigger multiple concurrent care interventions simultaneously. Residual collinearity between these predictors cannot be excluded and may have influenced the model estimates. This should be considered when interpreting the odds ratios reported. External validation is required before these findings can be used for prospective risk stratification.
Conclusions
This comparative cohort study identifies systemic and organizational factors—including factors associated with social support gaps, restricted access to palliative care units, and late integration of structured end-of-life care planning—among the strongest independent predictors of prolonged hospitalization. Whether these associations reflect modifiable determinants of prolonged stay or surrogate markers of underlying clinical complexity remains to be established through prospective study.
The need for earlier and more coordinated interventions between care teams and social services, particularly focusing on discharge planning, is suggested by these findings. Expanding the analysis to include other variables, such as the role of Physical and Rehabilitation Medicine and Social Services early in patient care and designing a personalized intervention, would be valuable avenues for future research. Furthermore, a more detailed characterization of the factors affecting patient transfer to PCUs is warranted, given the low number of these events.
The data also reveal that a substantial proportion of patients referred to a PCU who were not transferred died during the same hospitalization. These findings support the rationale for prospective evaluation of interventions addressing systematic early discharge planning, proactive social services integration, and stronger integration between acute oncology services, palliative care, and community continuing care. The effective management of prolonged hospitalizations in oncology patients demands a multidisciplinary and coordinated approach, considering both clinical and social factors to optimize care and resource allocation.
The findings of this study do not exist in isolation but reflect well-documented structural challenges of the Portuguese National Health Service. Social frailty as a factor associated with prolonged hospitalization may be a symptom of insufficient coordination between acute hospital services and community social support networks. Portugal has one of the lowest ratios of long-term care beds per capita in the European Union, and the national network of integrated continued care (NNICC) remains under-resourced relative to the demand generated by an ageing population with increasing oncological prevalence. In this context, the acute oncology ward may serve, in some cases, as a default placement for patients who cannot be safely discharged—not because their clinical needs require it, but because timely alternatives, such as supported discharge to home or placement in a social care facility, are not always available.
Similarly, the bottleneck in PCU access identified in this study reflects a nationally recognized insufficiency. Despite the establishment of criteria for PCU referral within the NNICC framework, the number of available palliative care beds in Portugal remains substantially below estimated need. The median LOS of 41 days for patients transferred to a PCU, compared with 27 days for those referred but not transferred, is consistent with PCU waiting times functioning as the rate-limiting step—a finding with potential implications for health policy. These results support the case for a national strategy to expand PCU capacity, strengthen early integration of palliative care in oncology, and improve discharge coordination between hospitals, social services, and continuing care networks.
来源:Nature 健康护理主题 · nature.com